[1] Andrade L,Hoskoppal A,Hunt Martin M,et al.Intracranial aneurysm and coarctation of the aorta:prevalence in the current era[J].Cardiol Young,2021,31(2):229. [2] Dandapat S,Mendez-Ruiz A,Martínez-Galdámez M,et al.Review of current intracranial aneurysm flow diversion technology and clinical use[J].J Neurointerv Surg,2021,13(1):54. [3] Li K,Guo Y,Zhao Y,et al.Acute rerupture after coil embolization of ruptured intracranial saccular aneurysms:A literature review[J].Interv Neuroradiol,2018,24(2):117. [4] Flemming KD,Lanzino G.Management of Unruptured Intracranial Aneurysms and Cerebrovascular Malformations[J].Continuum (Minneap Minn),2017,23(1,Cerebrovascular Disease):181. [5] 姬培培,伍艳春,张庆英,等.动脉瘤性蛛网膜下腔出血手术治疗后患者的不良预后因素评估[J].中国医药,2021,16(12):1813. [6] Calviere L,Gathier CS,Rafiq M,et al.Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies[J].Front Neurol,2022,13(836268. [7] Kim D,Pyen J,Whang K,et al.Factors associated with rebleeding after coil embolization in patients with aneurysmal subarachnoid hemorrhage[J].J Cerebrovasc Endovasc Neurosurg,2022,24(1):36. [8] Lu VM,Graffeo CS,Perry A,et al.Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia:a propensity-score matched cohort study[J].J Neurosurg,2019,1. [9] Larsen CC,Astrup J.Rebleeding after aneurysmal subarachnoid hemorrhage:a literature review[J].World Neurosurg,2013,79(2):307. [10] 樊建华,王正则,高连波.动脉瘤性蛛网膜下腔出血患者再出血的危险因素研究[J].中国全科医学,2019,22(3):275. [11] 孙振国,杨阳,孙建新,等.高级别动脉瘤性蛛网膜下腔出血再破裂的危险因素分析[J].临床神经外科杂志,2022,19(1):97. [12] 邢霞,皮红英,纪欢欢.颅内破裂动脉瘤患者术前再出血危险因素分析[J].中国卒中杂志,2019,14(8):775. [13] van Donkelaar CE,Bakker NA,Veeger NJ,et al.Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage:Rebleeding Aneurysmal Subarachnoid Hemorrhage Study[J].Stroke,2015,46(8):2100. [14] Tomasello A,Romero N,Aixut S,et al.Endovascular treatment of intracraneal aneurysm with pipeline embolization device:experience in four centres in Barcelona[J].Neurol Res,2016,38(5):381. [15] 刘洋,黄小龙,付浩,等.蛛网膜下腔出血老年患者神经功能预后与年龄界值的关系研究[J].中华神经创伤外科杂志,2020,6(4):208. [16] 王江涛.颅内动脉瘤开颅手术治疗预后不良的Logistic回归分析[J].哈尔滨医药,2022,42(5):56. [17] 张伊,付其昌,管生,等.未破裂颅内动脉瘤直径与其血流动力学、形态学及瘤壁强化的关系[J].中国介入影像与治疗学,2022,19(8):476. [18] 吕楠,陈士跃,王馨蕊,等.颅内未破裂动脉瘤形态学对高分辨率MR管壁成像瘤壁强化的影响因素分析[J].中国脑血管病杂志,2018,15(1):10. [19] 陈刘炜,卢昊,徐一,等.动脉瘤性蛛网膜下腔出血患者全身免疫炎症指数与Hunt-Hess分级的相关性[J].同济大学学报(医学版),2020,41(5):587. [20] 肖庆,焦汝开,周焜,等.血管内介入治疗颅内破裂动脉瘤82例预后及复发的影响因素分析[J].安徽医药,2021,25(8):1524. |